The potential role of amifostine (Ethyol®) in haematological malignancies

European Journal of Cancer

Volumn 32, Issue SUPPL. 4, 1996, Pages

  Gorin, N C ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

acute leukaemia; amifostine; autologous stem cell transplantation; purgery; stem cell protection

Indexed keywords

AMIFOSTINE; MAFOSFAMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CELL PROTECTION; CLINICAL TRIAL; HEMATOPOIETIC STEM CELL; HUMAN; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AMIFOSTINE; ANTINEOPLASTIC AGENTS; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; TUMOR STEM CELLS;

EID: 0029972257     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00331-0     Document Type: Article

References (22)

1. Autologous bone-marrow transplantation in acute myclocytic leukemia
2. High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumours: a study of 23 patients
3. Autologous bone marrow transplantation using marrow incubated with ASTA Z-7557 in adult acute leukemia
4. Detection of tumor contamination by polymerase chain reaction analysis in peripheral blood stem cells collected from patients with leukemia and lymphoma
5. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment
6. Detection and quantitiation of malignant cells in the peripheral blood of multiple myeloma patients
7. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
8. Direct demonstration that autologous bone marrow transplantation for solid tumours can return a multiplicity of tumorigenic cells
9. Autologous bone marrow transplantation for acute myeloblastic leukemia in first remission: a European survey of the role of marrow purging
10. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide
11. Purging of bone marrow in ABMT for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the EBMT Lymphoma Registry
12. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z-7557)
13. One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience
14. Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxy-cyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support
15. Preparation and successful engraftment of purified CD 34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma
16. Standardization and characterization of the procedure for in vitro treatment of human bone marrow with cyclophosphamide derivatives
17. Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z-7557)
18. Long-term preservation of bone marrow and stem cell pool in dogs
19. Collection, manipulation and freezing of haemopoietic stem cells
20. Autologous BMT in AML: the nine year experience at hematology university “La Sapienza” of Roma
21. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia
22. Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging